Navigation Links
Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
Date:12/12/2007

PLYMOUTH MEETING, Pa., Dec. 12 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today announced that Jack Armstrong, President and Chief Executive Officer of Genaera, is scheduled to present at the 2007 RBC Capital Markets Healthcare Conference. The presentation is part of an RBC Capital Markets' panel discussion of diabetes and obesity, entitled, "The Pharmaceutical Sweet Spot: Diabetes & Obesity," and will take place in New York on Thursday, December 13 at 10:00 a.m. ET.

This panel presentation is being webcast at: http:/www.wsw.com/webcast/rbc84qpanel23

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a Phase 1 trial in obesity. In addition, Genaera has a value- driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing Phase 2 clinical testing in asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. For further information, please see our website at http://www.genaera.com.


'/>"/>
SOURCE Genaera Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Genaera Elects New Board Member and Announces Executive Appointments
2. Genaera to Present at Biotech 2007 and BIO InvestorForum
3. Genaera Corporation Announces Third Quarter Financial Results
4. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
5. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
6. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
7. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
8. BioElectronics Corporation Announces Singapore and Malaysia Sales
9. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
10. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
11. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ovember24/PRNewswire-FirstCall/--deCODE,genetics,I...oticefrom,theNasdaqStockMarketthattradinginthecomp...9andaForm25-NSEwillbefiledwiththe,SecuritiesandExc...,fromlistingonNasdaq,unlessthecompanyfilesanappeal...asfiledsuchanappeal,which,willstaythesuspensionand...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: ...gandcommercializingnovelpainmanagementtherapies,an...ecutiveOfficer,isscheduledtopresentatthe21stAnnual...-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ,...fficer,willbeavailabletorespondtoquestionsduringth...
(Date:11/24/2009)..., TORONTO,Nov.24/PRNewswire-FirstCall/-HamiltonTh...adingproviderofadvancedlasersystemsandinstrumentsf...ayreportedoperationalandfinancialresultsforthethir...s,-Revenuewas$1.46millioncomparedwith$1.43million...ith66.1percentinQ3,2008,-Netlossreducedto$148,000c...
(Date:11/24/2009)...rogram Connects Customers with Partners Validated ...Genotek Products , Ottawa... leading provider of products for biological sampl... announced its new global partner program. The pro...ek,s partner community and is designed to help par...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
..., , High ... RT-PCR and microarray gene expression analysis...tion in , minutes: no grinding ...nt reagents protect and preserve , ... Faster and easier multi-sample , ...
...f siRNA applications, including , ...delivery of , hundreds to thous... studies describe performing trans...l formats. Ambion has developed two reagents, siPO... and siPORT siRNA , Electropora...
...tion efficiency and low cell , ...sful gene , silencing experimen... choosing the right transfection agent an...evels of transfection efficiency can be achieved ,...tocol is optimized for a , part...
Other Biology Technology:Hands-free Tissue Disruption No Homogenization Needed 2Hands-free Tissue Disruption No Homogenization Needed 3Hands-free Tissue Disruption No Homogenization Needed 4Hands-free Tissue Disruption No Homogenization Needed 5Hands-free Tissue Disruption No Homogenization Needed 6Hands-free Tissue Disruption No Homogenization Needed 7High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 2High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 3High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 4High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 5High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 6High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 7High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 8High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 9High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells 10Optimizing siRNA Transfection for RNAi 2Optimizing siRNA Transfection for RNAi 3Optimizing siRNA Transfection for RNAi 4Optimizing siRNA Transfection for RNAi 5Optimizing siRNA Transfection for RNAi 6Optimizing siRNA Transfection for RNAi 7Optimizing siRNA Transfection for RNAi 8Optimizing siRNA Transfection for RNAi 9Optimizing siRNA Transfection for RNAi 10Optimizing siRNA Transfection for RNAi 11
(Date:11/24/2009)...ning new doors to understanding how sounds associa...marine mammal or if they hear it at all. , The ... that NASA uses to detect flaws in the space shutt...cientists to peek inside the giant head of a whale...al replicas of a whale,s hearing anatomy using a b...
(Date:11/24/2009)...ican College of Medical Toxicology (ACMT) have sig... of the Journal of Medical Toxicology (JMT), the...2010. It was previously published by the Universi...ical Toxicology , an international, peer-reviewed ... practice of medical toxicology. The quarterly jo...
(Date:11/24/2009)...ber 24, 2009) New research on bacterial communiti...veals predictable temporal patterns, suggesting th...rs for monitoring climate change in the polar regi...dings of the National Academy of Sciences Early E...x rivers shifted synchronously over time, correlat...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Sigma Aldrich Elects George M Church as Director 14337 1Sigma Aldrich Elects George M Church as Director 14337 2ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results 5193 1Case Western Reserve University discovers Merkel cell originates from skin not the neural crest 10243 1Case Western Reserve University discovers Merkel cell originates from skin not the neural crest 10243 2
...homa County,s Use of PocketCop on BlackBerry Smart...rmed and In Touch, WALL, N.J., Nov. 20 BIO-key I...ader in finger-based biometric,identification and ...elevised report on the Oklahoma County Sheriff,s O... ABC affiliate in Oklahoma City. The,November 18th...
...hinas CO 2 emissions from using coal are set to d...n the context of mitigating global climate change....energy system, it is vital to minimise emissions w...vey (BGS) attended the launch of the Near Zero Emi... today. The aim of this study is to look at the fe...
...PITTSBURGH Carnegie Mellon University graduate eng...Lima de Azevedo, Benjamin Flath and Constantine Sa...competition called Tomorrows Energy Ambassadors, M...e contest, sponsored by Johnson Controls Inc., ask...rtant energy and sustainability issues in a letter...
Other Biology News:BIO-key(R) PocketCop(R) Project 'Leading the Nation' According to Televised Report 2UK scientists lead China closer to carbon capture and storage 2Carnegie Mellon students win contest 2Carnegie Mellon students win contest 3
...exchange media are rigid macroporous hydrophilic m...tes at moderate pressures, while the macroporous b...hilic matrix reduces nonspecific binding. Macro-Pr...exchanger with very high flow rates and resolution...
Rat siTrio from B-Bridge International
Mouse Anti-Aggrecan xxPEN Monoclonal Antibody, Unconjugated, Clone BC-4 from Abcam
Rabbit Anti-L Kynurenine Polyclonal Antibody, Unconjugated from Abcam
Biology Products: